Tuesday, May 21, 2024
HomeTagsATG-017

ATG-017

Antengene Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate ATG-017 in Combination with Opdiv (nivolumab) in Advanced Solid Tumors

Antengene Corporation Limited, a leading innovative, global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for cancer and other life-threatening...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics